Comparison

MK-8745 European Partner

Item no. TMO-T2471-100mg
Manufacturer TargetMol
CASRN 885325-71-3
Amount 100 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mL 200 mg 25 mg 50 mg 5 mg
Category
Type Molecules
Specific against other
Citations 1. Chowdhury A, et al. Leuk Lymphoma. 2012, 53(3), 462-471.
Smiles Fc1c(Cl)cccc1C(=O)N1CCN(Cc2cccc(Nc3nccs3)n2)CC1
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias Aurora Kinase inhibitor
Shipping Condition Cool pack
Available
Manufacturer - Targets
Aurora Kinase|||Apoptosis
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
431.91
Description
MK-8745 is a potent and selective Aurora A inhibitor.
Pathways
Chromatin/Epigenetic|||Apoptosis|||Cell Cycle/Checkpoint
Bioactivity
MK-8745 is a potent and selective Aurora A inhibitor with IC50 of 0.6 nM, more than 450-fold selectivity for Aurora A over Aurora B.
Receptor
Aurora A; Aurora B

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 100 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close